Unlocking the Potential of the Endocannabinoid System in Chiropractic Care
Register Tell a Friend About This EventTell a Friend
Unlocking the Potential of the Endocannabinoid System in Chiropractic Care

Certain CBD/CHABA products can now be used and sold in chiropractic clinics, but do you know the science behind it? More importantly, do you know which products you can use and how? Join us for this one-hour webinar presented by Versea Holdings as we outline role and the market of Cannabis Health and Beauty Aids, how best to integrate them into your practice, and how to answer common questions patients will ask you about them.

 Export to Your Calendar 10/29/2020
When: Thursday, October 29, 2020
12:00pm - 1:00pm
Where: ONLINE
United States
Contact: Jeff Curwen, CAE
206-878-6055


Online registration is available until: 10/29/2020
« Go to Upcoming Event List  

The number of patients trying CBD for their medical conditions is growing. According to the Hemp Business Journal, sales of cannabidiol (CBD), a component of the cannabis plant most prominently found in hemp, are projected to grow to $1.3 billion in the U.S. by 2022. 

 

Much of that growth has been spurred by hype media stories touting CBD as the new natural miracle drug. However, underlying all the media hype is real science. There has been an explosion of research into the endocannabinoid system (ECS), cannabinoids, and the use of cannabis derivatives for the treatment of a variety of health conditions. As a result, healthcare professionals have the opportunity to transform the lives of millions of patients for whom conventional medicine has failed by unlocking the potential of this new treatment approach. 

 

This short presentation will introduce podiatrists to the concept of targeting the endocannabinoid system with cannabidiol as an additional option for achieving patient outcomes.

 

After this presentation you should be able to:

  • Describe the role the endocannabinoid system plays in the body
  • Describe the role cannabis-derivatives can play in activating the endocannabinoid system
  • Recall evidence for the use of cannabinoids in conditions relevant to chiropractic care.
  • Replicate the way other Chiropractors are already using cannabidiol in their practices.

 

Verséa Holdings is a US-based pharmaceutical company, focused on clinical research and novel scientific discoveries for the development of new treatment options for inflammatory and other debilitating diseases. The Verséa™ commercial brand cannabidiol (CBD) Hemp product line is available through practitioners nationwide. The company was founded by a group of healthcare professionals with decades of proficiency from the segments of medical academia, pharmaceutical executives and practicing physicians, all with expertise in pain management and disorders of the central nervous system

(CNS). It is with this deep bench of know-how and the desire to be a part of the solution to a significant medical crisis they have witnessed firsthand, that Verséa was created.

 

 

Sell more with less effort.

 

Registration Fees

Nonmembers     $19.99
WSCA Members $9.99
Olympic Members FREE
Rainier Members FREE

 

 

Refund Policy

  • 30 days from the event: full refund issued
  • 14 days from the event: 50% refund issued
  • 13 days or less: no refund
  • No show: no refund regardless of when you paid 

WSCA Leadership & Platinum Partners

Advertise with WSCA


Reach nearly 1,100 Chiropractors in Washington State through WSCA's award-winning magazine, the Plexus.

New Edition of Plexus


 
IN THIS ISSUE

The story of Mabel Heath Palmer, The Marikubo Trial: a landmark chiropractic case, and the Marketplace Chiropractic Buying Guide

 



Contact

WSCA
21400 International Boulevard, Suite 207, Seatac, WA 98198 (206) 878-6055


Connect With Us!

     

BluePay

 

Membership Software Powered by YourMembership  ::  Legal